Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
-
Beatriz Tavira
,
Carmen Díaz-Corte
Abstract
Background: Tacrolimus (Tac) is an immunosuppressive drug used to prevent post-transplant (PT) organ rejection. Continuous Tac monitoring is necessary to adjust the dose and prevent toxicity or rejection. Tac is metabolized by cytochrome-P450 (CYP) enzymes, and variation at the CYP and other drug metabolizing enzymes could influence Tac bio-availability and dose requirements. Our aim was to define the effect of DNA variants at 16 drug metabolising enzymes on Tac dose in patients with kidney transplants.
Methods: The REDINREN Pharmacogenetics Project was a multicenter study designed to evaluate the effect of DNA polymorphisms on Tac dose requirements. A total of 200 patients who received a first cadaveric kidney and Tac as primary immunosuppressive drug were genotyped for 96 DNA polymorphisms on 16 genes. Significant associations were further replicated in a second group of 200 patients. The Tac daily dose was adjusted to achieve a blood concentration of 10–15 ng/mL in the period 0–3 months PT, and 5–10 ng/mL thereafter. The dose of tacrolimus dose and blood concentrations were compared between genotypes at 1 week, 6 months, and 1 year PT.
Results: The CYP3A5 genotype (SNP rs776746) was the strongest predictor of Tac dose requirements. Patients who were CYP3A5*3*3 (CYP3A5 non-expressors) received significantly higher Tac dose at 1 week, 6 months, and 1 year PT (p<0.0001). At 1 week, 41% of the CYP3A5 non-expressors achieved target blood concentrations compared to 26% of the CYP3A5 expressors (p=0.007). We also found a significant effect of CYP3A4 genotype (SNP rs2740574) on Tac dose requirements in patients who were CYP3A5 non-expressors. None of the other polymorphisms were related to Tac dose requirements or modified the effect of the CYP3A5 genotype.
Conclusions: rs776746 (CYP3A5) and rs2740574 (CYP3A4) were the only SNPs associated with Tac dosage. The genotyping of these polymorphisms could be a useful pharmacogenetic tool to determine the Tac dose immediately after transplantation.
©2011 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Editorials
- Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against?
- Circulating macrocomplexes: old wine in new bottles?
- Review
- Laboratory assessment of new anticoagulants
- Minireviews
- Biomarkers in Alzheimer’s disease
- Analytical variability in sport hematology: its importance in an antidoping setting
- The plodding diagnosis of monogenic autoinflammatory diseases in childhood: from the clinical scenery to laboratory investigation
- Opinion Paper
- Collective opinion paper on findings of the 2010 convocation of experts on laboratory quality
- Genetics and Molecular Diagnostics
- Genetic variability of the fructosamine 3-kinase gene in diabetic patients
- Identification of Bcl-2/IgH fusion sequences using real-time PCR and chip-based microcapillary electrophoresis
- Performance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body composition
- Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
- General Clinical Chemistry and Laboratory Medicine
- Quality Indicators in Laboratory Medicine: from theory to practice
- Implementation of computerized add-on testing for hospitalized patients in a large academic medical center
- Human growth hormone (GH) immunoassay: standardization and clinical implications
- Coagulation assays based on the Luminescent Oxygen Channeling Immunoassay technology1)
- Trefoil factor family peptides in human saliva and cyclical cervical mucus. Method evaluation and results on healthy individuals
- Steroid binding properties of the 2nd WHO International Standard for sex hormone-binding globulin
- Thyroxin overdose due to rheumatoid factor interferences in thyroid-stimulating hormone assays
- Cancer Diagnostics
- Quantification of HER2 autoantibodies in the amplification phenomenon of HER2 in breast cancer
- Glycosylation of proteins in healthy and neoplastic human salivary glands – a preliminary study
- Infectious Diseases
- Quantification of cerebrospinal fluid lactic acid in the differential diagnosis between HIV chronic meningitis and opportunistic meningitis
- Cardiovascular Diseases
- Carotid restenosis is associated with plasma ADMA concentrations in carotid endarterectomy patients
- High concentrations of asymmetric dimethylarginine are associated with ST-segment resolution failure after reperfusion for acute myocardial infarction
- An increase in serum uric acid concentrations is associated with an increase in the Framingham risk score in Korean adults
- The effect of a one-year weight reduction program on serum uric acid in overweight/obese children and adolescents
- False positive troponin result caused by a true macrotroponin
- Letters to the Editor
- Patient safety: patient identification wristband errors
- Prevalence of hemolytic specimens referred for arterial blood gas analysis
- “Triage” of lymphoid malignancies in the peripheral blood using the Extended Immunofluorescent Application of the CELL-DYN Sapphire automated hematology analyzer
- Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients
Articles in the same Issue
- Editorials
- Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against?
- Circulating macrocomplexes: old wine in new bottles?
- Review
- Laboratory assessment of new anticoagulants
- Minireviews
- Biomarkers in Alzheimer’s disease
- Analytical variability in sport hematology: its importance in an antidoping setting
- The plodding diagnosis of monogenic autoinflammatory diseases in childhood: from the clinical scenery to laboratory investigation
- Opinion Paper
- Collective opinion paper on findings of the 2010 convocation of experts on laboratory quality
- Genetics and Molecular Diagnostics
- Genetic variability of the fructosamine 3-kinase gene in diabetic patients
- Identification of Bcl-2/IgH fusion sequences using real-time PCR and chip-based microcapillary electrophoresis
- Performance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body composition
- Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
- General Clinical Chemistry and Laboratory Medicine
- Quality Indicators in Laboratory Medicine: from theory to practice
- Implementation of computerized add-on testing for hospitalized patients in a large academic medical center
- Human growth hormone (GH) immunoassay: standardization and clinical implications
- Coagulation assays based on the Luminescent Oxygen Channeling Immunoassay technology1)
- Trefoil factor family peptides in human saliva and cyclical cervical mucus. Method evaluation and results on healthy individuals
- Steroid binding properties of the 2nd WHO International Standard for sex hormone-binding globulin
- Thyroxin overdose due to rheumatoid factor interferences in thyroid-stimulating hormone assays
- Cancer Diagnostics
- Quantification of HER2 autoantibodies in the amplification phenomenon of HER2 in breast cancer
- Glycosylation of proteins in healthy and neoplastic human salivary glands – a preliminary study
- Infectious Diseases
- Quantification of cerebrospinal fluid lactic acid in the differential diagnosis between HIV chronic meningitis and opportunistic meningitis
- Cardiovascular Diseases
- Carotid restenosis is associated with plasma ADMA concentrations in carotid endarterectomy patients
- High concentrations of asymmetric dimethylarginine are associated with ST-segment resolution failure after reperfusion for acute myocardial infarction
- An increase in serum uric acid concentrations is associated with an increase in the Framingham risk score in Korean adults
- The effect of a one-year weight reduction program on serum uric acid in overweight/obese children and adolescents
- False positive troponin result caused by a true macrotroponin
- Letters to the Editor
- Patient safety: patient identification wristband errors
- Prevalence of hemolytic specimens referred for arterial blood gas analysis
- “Triage” of lymphoid malignancies in the peripheral blood using the Extended Immunofluorescent Application of the CELL-DYN Sapphire automated hematology analyzer
- Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients
